Cellebrite DI (CLBT) Total Current Liabilities (2020 - 2025)

Cellebrite DI's Total Current Liabilities history runs 6 years deep, the most recent figure standing at $369.7 million for Q4 2025.

• In Q4 2025, Total Current Liabilities rose 25.09% year-over-year to $369.7 million; the TTM figure through Dec 2025 stood at $369.7 million (up 25.09% YoY), while the FY2025 annual figure was $369.7 million, up 25.09% from the prior year.
• Total Current Liabilities was $369.7 million for Q4 2025 at Cellebrite DI, up from $316.9 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $403.7 million in Q3 2021 to a low of $170.6 million in Q1 2022.
• Historically, Total Current Liabilities has averaged $252.5 million across 5 years, with a median of $235.9 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Total Current Liabilities tumbled 52.99% in 2022, then soared 30.66% in 2025.
• A 5-year view of Total Current Liabilities shows it stood at $186.6 million in 2021, then gained by 11.36% to $207.8 million in 2022, then grew by 22.16% to $253.8 million in 2023, then grew by 16.42% to $295.5 million in 2024, then gained by 25.09% to $369.7 million in 2025.
• The last three Total Current Liabilities figures came in at $369.7 million (Q4 2025), $316.9 million (Q3 2025), and $310.0 million (Q2 2025), per Business Quant data.